Leptin, the product of the ob gene, is secreted from white adipocytes and regulates food intake and whole-body energy metabolism. In rodents and humans, leptin gene expression is under complex endocrine and metabolic control, and is strongly influenced by energy balance. Growth hormone (GH) has myriad effects on adipose tissue metabolism. The primary aim of this study was to determine the ability of GH to regulate leptin mRNA expression in bovine adipose tissue in vitro and in vivo. Incubation of subcutaneous adipose tissue explants for 24 h with GH alone had no effect on bovine leptin gene expression, whereas high concentrations of insulin or dexamethasone (DEX) potently stimulated bovine leptin mRNA abundance. GH, in combination with high concentrations of insulin, DEX, or both, attenuated the ability of insulin or DEX to stimulate leptin expression in vitro.
Introduction
Leptin, the product of the ob gene, has been implicated in the regulation of food intake and energy homeostasis in rodents and man. The expression of leptin in adipose tissue is highly correlated with adipose mass and adipocyte size in fully fed individuals (see reviews, , Houseknecht et al. 1998 . In addition, leptin gene expression in rodents and humans is under complex endocrine regulation as insulin, glucocorticoids and estrogen have been shown to stimulate leptin expression, whereas leptin concentrations in adipose tissue and serum are downregulated under conditions such as fasting, adrenergic stimulation, and cold exposure , Houseknecht et al. 1998 .
Growth hormone (GH) plays an important role in the regulation of whole-body energy utilization. GH directly regulates adipocyte metabolism in domestic animals, rodents and man; GH treatment attenuates insulinstimulated lipogenesis and enhances the adipocyte response to adrenergic stimulation of lipolysis, with the net effect of partitioning nutrients away from the fat cell (see review, Etherton & Bauman 1998 ). Long-term GH treatment of humans and animals significantly reduces adiposity and increases lean body mass. Furthermore, in growing animals in positive energy balance, exogenous GH treatment causes a reduction in food intake (Etherton & Bauman 1998) , suggesting that GH may act on central feeding centers in addition to regulating peripheral tissue metabolism.
Given the profound effects of GH on fat cell metabolism, one might expect that GH would regulate leptin gene expression also. The published data concerning the effect of GH on leptin expression are equivocal. Hardie et al. (1996) reported that incubation of isolated rat adipocytes with GH or insulin-like growth factor (IGF)-1 in culture had no effect on leptin synthesis or secretion, whereas others have reported that high concentrations of IGF-1 (100 nM) inhibit dexamethasone (DEX)-induced leptin expression in rat adipose tissue (Reul et al. 1997) . Several studies (Considine 1997 , Matsuoka et al. 1999 , Miyakawa et al. 1998 , Rauch et al. 1998 have examined the effect of long-term administration of GH to GHdeficient patients; however, the results are difficult to interpret, as they are confounded by complex endocrine disorders, GH-induced changes in adiposity, or both. Therefore a primary aim of this work was to determine the effect of short-term GH treatment of healthy, growing animals on leptin gene expression in subcutaneous adipose tissue, before the occurrence of GH-induced changes in adiposity. An additional aim was to determine the effect of GH treatment on insulin and DEX-stimulated leptin expression in vitro. We provide the first evidence that GH can regulate leptin gene expression in bovine adipose tissue in vivo and in vitro, and that mechanisms appear to be independent of adipose tissue mass.
Materials and Methods

Animals and experimental design
All experiments were approved by the Purdue University Committee for Animal Care and Use. Castrate male cattle (Angus, n=12, 296·9 27 kg body weight) were used to determine effects of in vivo administration of GH on leptin expression. Animals were fed a standard complete diet for growing cattle, which was available ad libitum. The diet was formulated from corn, corn silage and protein-mineral supplement to meet National Research Council (1984) requirements for growing cattle (12·5% crude protein, 1·28 mcal net energy gain/kg dry matter). Each animal served as its own control; animals were randomly assigned to Control or GH treatment groups to receive daily injections, respectively, of saline or GH (200 µg/kg body weight per day; Sometribov, Monsanto Corporation, St Louis, MO, USA) for 3 days, following which a subcutaneous adipose tissue sample was obtained by surgical biopsy as described elsewhere (Houseknecht et al. 1996) . After a 7-day interim period for recovery from previous experimental treatment and biopsy surgery, animals received the alternate treatment and a second adipose tissue biopsy was collected. Adipose tissue samples were snap frozen and stored at 80 C until required for analysis for leptin and IGF-1 mRNA abundance. The short duration of GH treatment was chosen to alleviate the confounding effects of GH on adiposity, and we have previously shown that short-term GH treatment (2-3 days) results in significant alterations in the adipose tissue response to hormonal stimulus in cattle (Houseknecht et al. 1995 , Houseknecht & Bauman 1997 . The ability of GH to induce IGF-1 mRNA expression in adipose tissue was used as a positive control, indicating a normal animal response to GH (Coleman et al. 1994 ).
Blood sampling and analyses
Two days before initiation of in vivo treatments, a subset of animals (n=8) were fitted with indwelling jugular catheters for frequent blood sampling. Plasma samples were collected, beginning 1 h before the third GH injection (or corresponding time during the control period). Samples were collected over 24 h for calculation of mean daily GH concentrations ( 60, 30, +10, 20, 30, 40, 50, 60, 80, 100, 120, 150, 180, 240, 300, 360, 480, 600, 720, 840 , 1000 and 1440 min relative to injection). Concentrations of GH in plasma were quantified by RIA as previously described (Mollett & Malven 1982) . Plasma samples were analyzed by RIA for concentrations of insulin (Linco, St Charles, MO, USA) and cortisol (Coat-A-Count kit, Diagnostic Products, Los Angeles, CA, USA). Concentrations of free fatty acids in plasma were determined using a colorimetric kit (Wako NEFA kit, Biochemical Diagnostics, Edgewood, NY, USA). Inter-and intra-assay coefficients of variation were less than 10% for all assays.
Adipose tissue culture
Subcutaneous adipose tissue (15 g/animal) was collected from castrate male cattle (n=11; 552·4 48 kg body weight; all hormonal treatments were tested within each sample) immediately after exanguination. Adipose tissue explant slices (100 mg) were prepared using a microtome after dissection to remove connective tissue. Explants were incubated (1 g adipose tissue explants/treatment) in Medium 199 (25 ml/g explants; 5 mM glucose and acetate concentrations; Sigma, St Louis, MO, USA) supplemented with varying concentrations of hormones: basal (no hormone), bovine insulin (1, 10, 100 nM; Sigma), DEX (10, 100 nM; Sigma), GH (4, 40 ng/ml; Monsanto), insulin+DEX (100 nM each), insulin+GH (100 nM insulin, 40 ng/ml GH), GH+DEX (100 nM DEX+ 40 ng/ml GH), insulin+DEX+GH (100 nM insulin and DEX, 40 ng/ml GH). The concentrations of hormones used span the range reported to be effective in regulating leptin expression in rodent and human adipose tissue (Hardie et al. 1996 , Kolaczynski et al. 1996 , Slieker et al. 1996 . After 24 h in culture (37 C, 5% CO 2 ), explants were removed from the media and snap frozen until required for analysis for leptin mRNA abundance. Total RNA was extracted from adipose tissue as described elsewhere (Chomczynski & Sacchi 1987) .
Ribonuclease protection analyses
To quantify the abundance of bovine leptin mRNA in subcutaneous adipose tissue, a ribonuclease protection assay (RPA) was developed using a bovine-specific leptin riboprobe as described by Ji et al. (1998) . Briefly, a 27-bp bacteriophage T7 promoter sequence was added synthetically to the 5 end of antisense leptin primer ( Ji et al. 1998) . The resulting PCR product yields an antisense RNA when transcribed in vitro with T7 RNA polymerase. The transcription reaction was performed with 50 µCi [ -32 P]UTP (800 Ci/mmol) to generate a radiolabeled ribonucleotide probe. The in vitro transcription and RPA were accomplished using a commercially available kit (Maxiscript T7+RPA II, Ambion, Austin, TX, USA). Ten micrograms bovine adipose RNA was hybridized to the labeled probe overnight at 45 C. For quantification purposes, each RNA was co-hybridized to an 18S probe (Ambion). Single-stranded RNA was then digested with a 1 : 50 mixture of RNase I (250 U/ml)-RNase T1 (10 000 U/ml) for 1 h and protected bands were separated by gel electrophoresis (8 M urea, 5% acrylamide). Band intensities were quantified by densitometry or cutting the gel and quantifying radioactivity in gel slices (d.p.m./slice; in vitro samples only), or by both techniques. Quantification of radiation in gel slices was highly correlated with densitometry values (data not shown).
Abundance of IGF-1 mRNA in subcutaneous adipose tissue samples was quantified by RPA using an IGF-1 cDNA that represents a 147 bp portion corresponding to exon 3 as described by TaylorRoth et al. (1998;  a generous gift of Dr Alan Grant, Purdue University). The antisense strand was used to synthesize a labeled riboprobe using T3 RNA polymerase (Promega, Madison, WI, USA). One milligram template was labeled using NEN [ -32 P] (800 Ci/mmol). The probe was digested with DNase I for 30 min at 37 C and gel purified. Twenty micrograms bovine adipose RNA was hybridized to 100 000 c.p.m. of probe at 45 C overnight. Each sample was also hybridized to an 18S low activity probe to assess uniformity of RNA loading. Non-hybridized RNA was digested with a 1 : 50 mixture of RNase I (250 U/ml)-RNase T1 (10 000 U/ml): buffer (Ambion) for 30 min at 37 C. The RNA was precipitated, reconstituted in loading buffer and electrophoresed in a denaturing (8 M urea, 5% acrylamide) gel. Band intensity was quantified by densitometry.
Statistical analyses
Data were analyzed by ANOVA using the STATVIEW program for Macintosh (Abicus, CA, USA). When the main effect of treatment was found to be significant (P>0·05), differences among means were determined using Fisher's protected least significant difference post hoc test. Data are presented as means ...
Results and Discussion
Endocrine regulation of leptin expression in vitro
To our knowledge, there is currently no published literature describing the direct, endocrine regulation of leptin gene expression in bovine adipose tissue (in vitro). Therefore we tested the ability of varying concentrations and combinations of insulin, DEX and GH to regulate leptin expression in tissue culture (Fig. 1) . Both insulin and DEX, at high concentrations, significantly stimulated bovine leptin mRNA abundance compared with basal values (P<0·05)which is consistent with several reports in rodents and humans (Hardie et al. 1996 , Kolaczynski et al. 1996 , Slieker et al. 1996 , but conflict with findings of others (Reul et al. 1997 , Halleux et al. 1998 . We observed no additive effect of insulin and DEX, similar to the findings of , but in contrast to data reported by Hardie et al. (1996) . Leptin gene expression was not significantly increased by GH treatment alone; however, GH attenuated the stimulatory effects of high concentrations of insulin, DEX, or both. Specifically, leptin mRNA abundance was significantly lower (P<0·03) for 100 nM insulin + 40 ng/ml GH compared with 100 nM insulin. In addition, leptin mRNA abundance was lower (P<0·07) for 100 nM insulin+100 nM DEX than for 100 nM DEX. Finally, when explants were incubated with high concentrations of GH, insulin and DEX in combination, GH completely attenuated the increase in expression observed with insulin+DEX. Figure 1 Endocrine regulation of leptin mRNA abundance in bovine subcutaneous adipose tissue explant culture. Subcutaneous adipose tissue was collected at sacrifice from castrate male cattle (n=11; 552·4 48 kg body weight). Explants were prepared from each animal and incubated for 24 hr in Medium 199 in the absence (Control = basal) and presence of insulin (IN), GH or DEX, or combinations thereof: IN (1, 10, 100 nM), DEX (10, 100 nM), GH (4, 40 ng/ml), IN+DEX (100 nM each), IN+GH (100 nM insulin, 40 ng/ml GH), GH+DEX (100 nM DEX+40 ng/ml GH), IN+DEX+GH (100 nM insulin and DEX, 40 ng/ml GH). After incubation, mRNA was prepared from explants and analyzed for leptin mRNA abundance by ribonuclease protection analysis using a bovine-specific leptin probe. Data represent means for 11 animals (tissue from each animal was subjected to all treatments). *P<0·05 compared with Control.
Effect of exogenous GH administration on plasma GH and IGF-1 mRNA abundance
Next, we chose to expand our findings to examine the effect of bovine GH administration in vivo on leptin gene expression. Daily administration of GH significantly (P<0·001) increased average daily circulating GH concentrations compared with the control period (n=9; control: 2·1 0·6 ng/ml, GH: 62·4 6 ng/ml). Induction of IGF-1 mRNA in adipose tissue in response to GH treatment was used as a positive control, to ensure that animals were eliciting a known biological response to GH treatment. This is especially important, given the short duration of GH treatment, in which no observable change in growth rate or food intake could be quantified. Three of the 12 animals used in this experiment did not acclimatize to the metabolism stalls in which they were housed, as indicated by aggressive behavior during blood sampling, reduced food intake (9·8 1·2 kg dry matter intake/day compared with 13·1 0·7 kg/day for fully acclimatized animals) and lack of body weight gain over the course of the study (both control and GH treatment periods). Consistent with being in zero or negative energy balance, these animals exhibited no increase in IGF-1 expression in response to GH despite significantly increased plasma GH concentrations (n=3; 69·1 15·0 ng/ml). Therefore, data from this small subset of animals were removed from the means presented.
In the remaining animals (n=9), GH treatment caused a significant (P<0·001), 4·8-fold, increase in IGF-1 mRNA abundance in adipose tissue. This is consistent with results previously reported in the pig (Coleman et al. 1994) and with increased circulating IGF-1 reported in GH-treated animals (see review, Etherton & Bauman 1998) .
Effect of exogenous GH on plasma hormones and metabolites
Exogenous GH treatment caused a twofold increase in plasma insulin concentrations, with no change in plasma cortisol concentrations (Table 1) . These data are consistent with previous reports on the effect of GH treatment of cattle (Dunshea et al. 1995 , Bauman & Vernon 1996 . Furthermore, there was no effect of exogenous GH on plasma non-esterified fatty acid concentrations (Table 1) .
Effect of GH on leptin mRNA abundance in subcutaneous adipose tissue
GH treatment significantly (P<0·001) increased leptin mRNA abundance in animals exhibiting a positive IGF-1 response (Fig. 2) . Interestingly, the three animals in zero/negative energy balance that did not respond to GH with increased IGF-1 exhibited a significant downregulation of leptin expression in response to GH treatment (50% reduction; data not shown). Accordingly, concentrations of leptin mRNA were highly correlated with adipose tissue IGF-1 mRNA concentrations during both positive and zero/negative energy balance (n=12, r=0·81, P<0·001; Fig. 3 ).
General Discussion
We have provided evidence that GH can regulate leptin gene expression independently of GH-induced effects on adiposity. We tested this hypothesis using both in vitro and in vivo approaches, and provide the first evidence of GH . Approximately 18 h after the third injection, a subcutaneous adipose tissue biopsy was collected for analysis of leptin gene expression. Total mRNA was extracted from tissues and analyzed for leptin mRNA abundance by ribonuclease protection analysis using a bovine-specific leptin riboprobe. Upper panel: a representative experiment; lower panel: data from all animals (n=9). Treatment of animals for 3 days with bovine GH significantly increased leptin mRNA abundance compared with the control period (*P<0·001).
regulation of leptin gene expression in cattle. It has been well documented in studies with rodents and humans that insulin and glucocorticoids are potent stimulators of leptin gene expression (see reviews, , Houseknecht et al. 1998 . Recently, Isozaki et al. (1999) have reported that GH administration (7 days) to obese, hyperleptinemic Zucker fatty rats reduced leptin mRNA expression in visceral, but not subcutaneous, adipose tissue. However, there is a paucity of data that indicate that GH regulates leptin expression in adipose tissue of normal animals, independent of GH-induced changes in adiposity. Work by Hardie et al. (1996) showed that, when isolated rat adipocytes were incubated with either GH or IGF-1 alone, there was no effect on leptin secretion into the incubation medium, in contrast to increased secretion in response to insulin or glucocorticoids. We extended the work of Hardie et al. (1996) to include incubation of bovine adipose tissue explants with insulin, DEX, and GH alone and in combination, and confirmed that GH alone had no effect on leptin gene expression in bovine subcutaneous adipose tissue. However, when incubated in combination, GH attenuated the insulin-or DEXinduced stimulation of leptin gene expression. These in vitro data are consistent with work of others (see reviews, Bauman & Vernon 1993 , Etherton & Bauman 1998 ) that has shown that one effect of exogenous GH treatment is to inhibit insulin-mediated events in the adipocyte, such as stimulation of lipogenesis, inhibition of lipolysis and activation of adipogenic genes.
To examine further the role of GH in regulating leptin expression in adipose tissue, and to delineate endocrine mechanisms underlying leptin gene expression in cattle, we extended our work to include short-term exogenous GH treatment in vivo. Much of the literature in which the effects of exogenous GH of human subjects on leptin gene expression has been examined is difficult to interpret, because of the confounding effects of GH deficiency or chronic disease on leptin expression, in addition to GHinduced changes in adiposity. We hoped to minimize such confounding effects in our study by choosing a short duration of treatment (3 days) and treating normal animals that had no GH-related pathology. We were fairly confident that this short window of treatment should be sufficient to reveal the effects (if any) of GH on adipose tissue leptin expression, as we and others (Houseknecht et al. 1995 , Kerber et al. 1998 have shown that GHinduced changes in adipocyte biology, such as an increased response to -adrenergic agents and a reduced response to insulin, are in place within 15-24 h of treatment. Indeed, after 3 days of GH treatment, there was a significant up-regulation of adipose tissue IGF-1 mRNA, consistent with an appropriate biological response to GH (Coleman et al. 1994) . Furthermore, the GH-induced up-regulation of IGF-1 mRNA in adipose tissue was accompanied by a significant increase in leptin mRNA abundance.
The differing effects of GH on bovine leptin gene expression we report in the in vitro versus in vivo studies highlights the complexity of the in vivo system. The simplified in vitro system provides evidence that GH can modulate leptin expression, presumably via alteration in tissue response to hormones such as insulin and DEX. In vivo, the hormonal and nutritional milieu are more complex and, as GH inhibited leptin gene expression in vivo, it is tempting to speculate that GH effects are modulated by other hormonal and nutritional factors. The fact that others (Hardie et al. 1996 , Isozaki et al. 1999 have shown no direct effect of IGF-1 on leptin gene expression supports the notion that GH effects on leptin expression are not mediated by IGF-1. However, others (Boni-Schnetzler et al. 1999 , Reul et al. 1997 have reported a negative effect of IGF-1 on leptin gene expression, thus more research is needed to clarify if the effects of GH on leptin gene expression are mediated via effects on IGF-1.
The high correlation between IGF-1 expression and leptin expression in adipose tissue was quite striking. Coleman et al. (1994) previously reported that GH potently stimulates IGF-1 gene expression in adipose tissue of pigs; to our knowledge, our data are the first such report in cattle. Furthermore, it was interesting that, in the three animals that were in zero/negative energy balance during both the control and GH treatments, there was a significant down-regulation in leptin expression and a downregulation or no change in IGF-1 expression in response to GH (Fig. 3) . Thus the strong correlation between leptin and IGF-1 mRNA abundance holds for all animals tested, regardless of response to GH. Similarly, Fine et al. (1998) have recently reported a high correlation between adipose tissue leptin and IGF-1 expression in fed and fasted rats. However, although leptin and IGF-1 mRNA expression are correlated in adipose tissue of rodents and cattle, these data do not prove that leptin gene expression is regulated by IGF-1.
The reciprocal effects of GH to stimulate or inhibit leptin gene expression, depending upon the animal's energy balance, are consistent with the feeding behavior commonly observed with GH treatment. When growing animals in positive energy balance are treated with exogenous GH, there is a characteristic decrease in food intake (see review, Etherton & Bauman 1998) . As experimentally induced increases in leptin have been shown to inhibit food intake in rodents (see reviews, , Houseknecht et al. 1998 , it is tempting to speculate that a GH-induced increase in leptin expression could provide such a signal to reduce food intake in cattle. Conversely, when GH is administered to animals in negative energy balance, there is typically an increase in food intake to support the increased metabolic demand incurred by GH treatment (Etherton & Bauman 1998) . Again, on the basis of rodent data, a GH-induced decrease in leptin expression could provide a profound stimulus to eat, under these conditions. Finally, several groups have reported that leptin regulates GH secretion in rodents (Carro et al. 1997 , Tannenbaum et al. 1998 , Vuagnat et al. 1998 , sheep (Roh et al. 1998) and pigs (Barb et al. 1998) , and that exogenous leptin is able to prevent the fasting-induced decrease in GH secretion, but not IGF-1 secretion, in fasting rats (LaPaglia et al. 1998) . Our data coupled with data on the regulation of GH secretion by leptin, highlight the important link between leptin and the GH-IGF-1 axis in communicating the nutritional and metabolic status of the animal, and have important implications in the regulation of animal growth and development.
